tag:blogger.com,1999:blog-5472921328078253036.post8314732409663890047..comments2024-01-27T19:53:22.965-08:00Comments on Current Research into Cures for Type-1 Diabetes: Results from a Phase-II ATG and GCSF Combination TrialJoshua Levyhttp://www.blogger.com/profile/05300553471793001620noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-5472921328078253036.post-70258647530607045602018-05-23T07:48:47.196-07:002018-05-23T07:48:47.196-07:00The great irony is that if a method were found to ...The great irony is that if a method were found to delay indefinitely the full development of type 1 diabetes in patients just beginning to show signs of it, that would strand the established cases and leave them without hope. Research institutes, state, charitable, and corporate sources of research funding alike would abandon efforts to cure the established cases on the theory that, oh well, we can now prevent diabetes from developing, so the disease is essentially cured, except for that pitiful batch of medical curiosities who already had full-blown diabetes, who will soon enough die out. Yet the only people who are now very interested in this research are those who will be stranded by it!<br /><br />I also worry about any tampering with the immune system or stimulating parts of the body to regrow, since implicit in both of those efforts, singly and even more so in combination, is priming the body eventually to develop cancer.<br /><br />Pre-screening people who had not yet shown symptoms of the disease would be extremely difficult, especially since so many cases appear without obvious genetic sources, so the screening efforts could not be well focused. Also, since the population of type 1 patients is still relatively small, the cost-benefit ratio of screening efforts would be low.<br /><br />Oscarhttps://www.blogger.com/profile/02915452402029137589noreply@blogger.com